NWI Management’s iShares Biotechnology ETF IBB Stock Holding History

NWI Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,500	Closed	-$938K	–	62
2025 Q3	$938K	Hold	6,500	–	–	0.05%	58
2025 Q2	$822K	Hold	6,500	–	–	0.04%	53
2025 Q1	$831K	Hold	6,500	–	–	0.1%	41
2024 Q4	$859K	Hold	6,500	–	–	0.04%	50
2024 Q3	$946K	Sell	6,500 -1,500	-19%	-$217K	0.02%	42
2024 Q2	$1.1M	Hold	8,000	–	–	0.04%	35
2024 Q1	$1.1M	Hold	8,000	–	–	0.03%	45
2023 Q4	$1.09M	Hold	8,000	–	–	0.03%	44
2023 Q3	$978K	Hold	8,000	–	–	0.05%	45
2023 Q2	$1.02M	Hold	8,000	–	–	0.18%	39
2023 Q1	$1.03M	Hold	8,000	–	–	0.11%	41
2022 Q4	$1.05M	Hold	8,000	–	–	0.23%	40
2022 Q3	$936K	Hold	8,000	–	–	0.16%	41
2022 Q2	$941K	Hold	8,000	–	–	0.06%	51
2022 Q1	$1.04M	Hold	8,000	–	–	0.12%	43
2021 Q4	$1.22M	Buy	+8,000	New	+$1.24M	0.08%	46
2020 Q3	–	Sell	-12,000	Closed	-$1.64M	–	43
2020 Q2	$1.64M	Buy	+12,000	New	+$1.53M	0.13%	32
2020 Q1	–	Sell	-16,000	Closed	-$1.93M	–	45
2019 Q4	$1.93M	Buy	+16,000	New	+$1.79M	0.08%	41
2018 Q2	–	Sell	-250,000	Closed	-$26.7M	–	27
2018 Q1	$26.7M	Buy	+250,000	New	+$27.7M	2.23%	15

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NWI Management's IBB Position: Q4 2025 in Review

NWI Management sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 6,500 shares — an estimated $938K sold.

NWI Management first reported a position in IBB in Q1 2018 and held it in 19 quarters. The position peaked at $26.7M in Q1 2018. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

NWI Management reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
NWI Management sold 6,500 iShares Biotechnology ETF shares in Q4 2025, an estimated $938K.
NWI Management first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 19 quarters.
NWI Management's iShares Biotechnology ETF position peaked at $26.7M in Q1 2018.
955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on NWI Management's 13F filing for Q4 2025, filed 17 Feb 2026.